Physicians at the University of Kentucky Markey Cancer Center are the first to perform a unique procedure to treat a rare and persistent type of ovarian cancer.
Sep 19, 2017
0
128
Determining which cancer patients are likely to be resistant to initial treatment is a major research effort of oncologists and laboratory scientists. Now, ascertaining who might fall into that category may become a little ...
Aug 22, 2017
0
40
A potential new therapeutic strategy for a difficult-to-treat form of ovarian cancer has been discovered by Wistar scientists. The findings were published online in Nature Cell Biology.
Jul 24, 2017
0
53
Most women diagnosed with ovarian cancer undergo surgery to remove as many of the tumors as possible. However, it is usually impossible to eliminate all of the cancer cells because they have spread throughout the abdomen. ...
May 23, 2017
0
37
Researchers have been trying to understand why up to 85 percent of women experience recurrence of high-grade serous ovarian cancer—the most common subtype of ovarian cancer—after standard treatment with the chemotherapy ...
May 1, 2017
0
41
Most ovarian cancer is diagnosed at such late stages that patients' survival rates are poor. However, if the cancer is detected earlier, five-year survival rates can be greater than 90 percent.
Apr 10, 2017
0
68
A team led by researchers from the Stanford University School of Medicine has demonstrated a way to diagnose cancer without resorting to surgery, raising the possibility of far fewer biopsies.
Apr 4, 2017
0
58
The National Institutes of Health has awarded a Washington University in St. Louis faculty member in the School of Engineering & Applied Science a total of $1.3 million to study new imaging techniques designed to better fight ...
Mar 30, 2017
0
0
A drug already used to slow tumor growth may also prevent infertility caused by standard chemotherapies, according to a study published online March 6 in the Proceedings of the National Academy of Sciences.
Mar 6, 2017
0
82
Levels of circulating tumor DNA (ctDNA) detected in a blood test are correlated with the size of ovarian cancers and can predict a patient's response to treatment or time to disease progression, according to a retrospective ...
Dec 20, 2016
0
11
